Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News The science behind shaving preparations: Innovations and essential properties Shaving has been a vital grooming ritual for centuries, evolving from rudimentary tools to sophisticated razors and highly… bypharmanewsdailyJanuary 27, 2025